PAIGE HOOD: Open Payments
NPI 1477038107 · DAWSONVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,412 in 81 payments from 20 companies in 2025. Trend: 2023 $1,320 · 2024 $1,324 · 2025 $1,412
Food & beverage: $1,412
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $228 |
| AstraZeneca Pharmaceuticals LP | 7 | $152 |
| Amgen Inc. | 12 | $151 |
| Lilly USA, LLC | 9 | $138 |
| Axsome Therapeutics, Inc. | 5 | $110 |
| Phathom Pharmaceuticals, Inc. | 8 | $95 |
| PFIZER INC. | 4 | $81 |
| Corcept Therapeutics | 3 | $77 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $57 |
| Novartis Pharmaceuticals Corporation | 3 | $53 |
Products named: OTEZLA, Ozempic, Auvelity, MOUNJARO, VOQUEZNA, JARDIANCE, Korlym, FARXIGA.
Industry payments across GA — which companies pay providers there.
